Joyce E Bischoff from Jamaica Plain, MA, age 66

Isbn (Books And Publications)

Impossible Data Warehouse Situations: Solutions from the Experts

view source

Author
Joyce Bischoff

ISBN #
0201760339

Data Warehouse: Practical Advice from the Experts

view source

Author
Joyce Bischoff

ISBN #
0135773709

Resumes

Principal Investigator

view source

Location:

Boston, MA

Industry:

Biotechnology

Work:

Harvard Medical School Oct 2000 - Oct 2010
Associate Professor
Harvard Medical School Oct 2000 - Oct 2010
Professor
Harvard Medical School Jul 1990 - Sep 2000
Assistant Professor
Boston Children's Hospital Jul 1990 - Sep 2000
Principal Investigator
Whitehead Institute Jul 1985 - Jun 1990
Post-Doctoral Fellow

Education:

Washington University School of Medicine In St. Louis 1980 - 1985
Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry, Philosophy Washington University In St. Louis 1980 - 1985
Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry, Philosophy Duke University 1976 - 1980
Bachelors, Bachelor of Arts, Chemistry

Skills:

Molecular and Cellular Biology
Biochemistry
Angiogenesis
In Vivo
Cell Biology
Medicine
Editor In Chief For Angiogenesis
Editorial Board Member Atvb

Interests:

Endothelial Plasticity In Cardiac Valves

Joyce Bischoff

view source

Location:

Phoenix, AZ

Work:

Bischoff Consulting
Retired

Joyce Bischoff

view source

Joyce Bischoff

view source

Us Patents

Tissue-Engineered Vascular Structures
view source
US Patent:

20040044403, Mar 4, 2004
Filed:

Sep 19, 2003
Appl. No.:

10/399092
Inventors:

Joyce Bischoff - Weston MA, US
Sunjay Kaushal - Baltimore MD, US
John Mayer Jr - Wellesley MA, US
Tjorvi Perry - Dedhan MA, US
International Classification:

A61F002/06
A61F002/24
US Classification:

623/001410, 623/002150, 623/916000
Abstract:

The present invention is directed to novel, less invasive and improved methods of tissue-engineering of constructs that require an endothelial surface such as blood vessels and heart valves. The constructs of the present invention possess long-term patency. The method of the present invention is particularly suited for making small diameter vessels to replace clogged or damaged coronary blood vessels, for making trileaflet heart valve conduits to replace damaged or malformed pulmonic and aortic valves, and for other vascular structures that require an endothelial surface.

Methods For Promoting Neovascularization
view source
US Patent:

20100040584, Feb 18, 2010
Filed:

Dec 19, 2007
Appl. No.:

12/520185
Inventors:

Juan M. Melero-Martin - Newton Highlands MA, US
Joyce E. Bischoff - Weston MA, US
Assignee:

CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
International Classification:

A61K 35/12
A61P 9/00
US Classification:

424 937
Abstract:

The success of tissue engineering and therapeutic neovascularization depends on the development of a microvascular network. The present invention provides methods for promoting neovascularization in tissue engineering constructs, tissue repair, and wound healing comprising endothelial and mesenchymal progenitor cells.

Methods And Compositions For The Treatment Of Proliferative Vascular Disorders
view source
US Patent:

20130029950, Jan 31, 2013
Filed:

Jul 26, 2012
Appl. No.:

13/558850
Inventors:

Joyce Bischoff - Weston MA, US
Shoshana Greenberger - Modiin, IL
Assignee:

CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
International Classification:

A61K 31/573
A61P 9/00
A61P 35/00
US Classification:

514171
Abstract:

The technology described herein is directed to methods and compositions for the treatment of proliferative vascular disorders, e.g. hemangioma. In some aspects, the methods and compositions described herein related to a mTOR inhibitor or nifedipine.

Engineered Vascular Adipose Tissue
view source
US Patent:

20130236429, Sep 12, 2013
Filed:

Sep 22, 2011
Appl. No.:

13/825081
Inventors:

Juan M. Melero-Martin - Newton MA, US
Joyce E. Bischoff - Weston MA, US
Assignee:

CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
International Classification:

A61K 35/36
A61K 35/28
US Classification:

424 937
Abstract:

Embodiments of the invention relate to methods, compositions and kits for the in vivo formation of vascularized new adipose tissue in a subject. Combination of endothelial progenitor cells (EPCs) and mesenchymal progenitor cells (MPCs) implanted in vivo in a subject work synergistically to promote the formation vascularized new adipose tissue.

Therapeutic Compositions And Methods For The Inhibition Of Angiogenesis
view source
US Patent:

20020187123, Dec 12, 2002
Filed:

May 6, 2002
Appl. No.:

10/138512
Inventors:

David Milstone - Chestnut Hill MA, US
Joyce Bischoff - Weston MA, US
Ying Yu - Boston MA, US
International Classification:

A61K038/20
A61K038/21
A61K038/22
US Classification:

424/085200, 424/085500, 424/085700, 514/012000
Abstract:

The present invention is directed to compositions and methods involving the combined use of an angiogenesis inhibitor and an inducer of endogenous E-selectin. Improved methods for treating patients by inhibiting blood vessel growth are described.